$QURE 4 SEC Filings

Filed On	Filing
07 Jul 2026	Form 4: Kapusta Matthew C, Director Received 21,082 shares by exercise or conversion ($409K) · Sold 21,082 shares ($952K)
02 Jul 2026	Form 4: Abi-Saab Walid, Chief Medical Officer Received 10,000 shares by exercise or conversion ($55.9K) · Sold 30,000 shares ($1.39M)
02 Jul 2026	Form 4: Kaye Jack, Director Received 21,167 shares by exercise or conversion ($496K) · Sold 21,167 shares ($983K)
30 Jun 2026	Form 4: Abi-Saab Walid, Chief Medical Officer Sold 1,434 shares ($67.2K)
26 Jun 2026	Form 4: Kapusta Matthew C, Director Received 4,128 shares by exercise or conversion ($131K) · Sold 6,696 shares ($335K) · Received 28,716 shares by exercise or conversion ($911K) · 1 more
22 Jun 2026	Form 4: Kapusta Matthew C, Director Received 62,581 shares by exercise or conversion ($1.21M) · Sold 164,429 shares ($7.29M) · Received 4,656 shares by exercise or conversion ($148K) · 1 more
22 Jun 2026	Form 4: Balachandran Madhavan, Director Received 11,685 shares by exercise or conversion ($292K) · Sold 11,685 shares ($526K)
22 Jun 2026	Form 4: Kaye Jack, Director Received 5,295 shares by exercise or conversion ($168K) · Sold 5,295 shares ($225K)
17 Jun 2026	Form 4: Balachandran Madhavan, Director Received 10,000 shares by exercise or conversion ($84.9K) · Sold 10,000 shares ($279K)
17 Jun 2026	Form 4: Potts Jeannette, Chief Legal Officer Sold 5,237 shares ($145K)
12 Jun 2026	Form 4: Meek David D., Director Received 7,550 shares as a grant or award · Granted 13,980 Stock Option (Right to Buy) · Sold 1,993 shares ($53.9K)
12 Jun 2026	Form 4: Gut Robert, Director Received 2,645 shares by exercise or conversion ($42.4K) · Sold 7,552 shares ($197K) · Received 7,550 shares as a grant or award · 2 more
12 Jun 2026	Form 4: O'Keefe Kylie, Chief Customer & Strat Officer Sold 15,936 shares ($431K)
12 Jun 2026	Form 4: Springhorn Jeremy P., Director Received 7,550 shares as a grant or award · Granted 13,980 Stock Option (Right to Buy) · Sold 1,993 shares ($53.9K)
12 Jun 2026	Form 4: Post Leonard E, Director Received 7,550 shares as a grant or award · Granted 13,980 Stock Option (Right to Buy) · Sold 1,993 shares ($53.9K)
12 Jun 2026	Form 4: Kaye Jack, Director Received 7,550 shares as a grant or award · Granted 13,980 Stock Option (Right to Buy) · Sold 1,993 shares ($53.9K)
12 Jun 2026	Form 4: Jacques Rachelle Suzanne, Director Received 7,550 shares as a grant or award · Granted 13,980 Stock Option (Right to Buy) · Sold 1,993 shares ($53.9K)
12 Jun 2026	Form 4: Balachandran Madhavan, Director Received 7,550 shares as a grant or award · Granted 13,980 Stock Option (Right to Buy) · Sold 1,993 shares ($53.9K)
05 Jun 2026	Form 4: Kaye Jack, Director Received 2,645 shares by exercise or conversion ($42.4K) · Sold 2,645 shares ($79.4K)
12 May 2026	Form 4: Abi-Saab Walid, Chief Medical Officer Received 25,000 shares by exercise or conversion ($140K) · Sold 45,000 shares ($1.13M)

Comments